Investment
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
MarketWatch
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
Read the full story at the original publisher
MarketWatch →
-
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growthMarketWatch15 hours ago
Leave a Reply